These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

886 related items for PubMed ID: 21413124

  • 21. Comparison between one-stent versus two-stent technique for treatment of left main bifurcation lesions: A large single-center data.
    Gao Z, Xu B, Yang Y, Qiao S, Wu Y, Chen T, Xu L, Yuan J, Chen J, Gao RL.
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1132-8. PubMed ID: 25614097
    [Abstract] [Full Text] [Related]

  • 22. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S, Burzotta F, Trani C, Todaro D, Talarico G, Porto I, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Schiavoni G, Crea F.
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [Abstract] [Full Text] [Related]

  • 23. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.
    Naganuma T, Chieffo A, Takagi K, Panoulas VF, Mitomo S, Sticchi A, Latib A, Miyazaki T, Sato K, Costopoulos C, Fujino Y, Montorfano M, Carlino M, Nakamura S, Colombo A.
    Catheter Cardiovasc Interv; 2015 Feb 15; 85(3):E63-9. PubMed ID: 25099758
    [Abstract] [Full Text] [Related]

  • 24. Unprotected left main stenting in the real world: five-year outcomes of the French Left Main Taxus registry.
    Mylotte D, Meftout B, Moynagh A, Vaquerizo B, Darremont O, Silvestri M, Louvard Y, Leymarie JL, Morice MC, Lefèvre T, Garot P.
    EuroIntervention; 2012 Dec 20; 8(8):970-81. PubMed ID: 23014945
    [Abstract] [Full Text] [Related]

  • 25. Long-term outcome of percutaneous coronary intervention for unprotected left main coronary artery disease.
    Wu XM, Liu CP, Lin WC, Kao HL.
    Int J Cardiol; 2010 Feb 04; 138(3):272-6. PubMed ID: 18804295
    [Abstract] [Full Text] [Related]

  • 26. Drug eluting stenting in bifurcation coronary lesions long-term results applying a systematic treatment strategy.
    Assali AR, Vaknin-Assa H, Lev E, Teplitsky I, Dvir D, Brosh D, Bental T, Battler A, Kornowski R.
    Catheter Cardiovasc Interv; 2012 Mar 01; 79(4):615-22. PubMed ID: 22162218
    [Abstract] [Full Text] [Related]

  • 27. Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function.
    Lee MS, Yang T, Biondi-Zoccai G, Sillano D, Cerrato E, Tarantini G, Xhaxho J, Aragon J, Sheiban I.
    Catheter Cardiovasc Interv; 2011 Jun 01; 77(7):945-51. PubMed ID: 20824773
    [Abstract] [Full Text] [Related]

  • 28. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.
    Lefèvre T, Ormiston J, Guagliumi G, Schultheiss HP, Quilliet L, Reimers B, Brunel P, Wijns W, Buettner HJ, Hartmann F, Veldhof S, Miquel K, Su X, van der Giessen WJ.
    J Am Coll Cardiol; 2005 Aug 16; 46(4):592-8. PubMed ID: 16098421
    [Abstract] [Full Text] [Related]

  • 29. Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study.
    Cassese S, De Luca G, Villari B, Berti S, Bellone P, Alfieri A, Montinaro A, Quaranta G, Marraccini P, Piscione F, MATRIX Study Investigators.
    Catheter Cardiovasc Interv; 2012 Sep 01; 80(3):408-16. PubMed ID: 21735531
    [Abstract] [Full Text] [Related]

  • 30. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL, Han YL, Zhang YJ, Ye F, Liu HW, Zhang JJ, Xu B, Jiang TM, Zhou YJ, Lv SZ.
    JACC Cardiovasc Interv; 2013 Dec 01; 6(12):1233-41. PubMed ID: 24239199
    [Abstract] [Full Text] [Related]

  • 31. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
    Lee MS, Sillano D, Latib A, Chieffo A, Zoccai GB, Bhatia R, Sheiban I, Colombo A, Tobis J.
    Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):15-21. PubMed ID: 19089930
    [Abstract] [Full Text] [Related]

  • 32. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
    Chen SL, Chen JP, Mintz G, Xu B, Kan J, Ye F, Zhang J, Sun X, Xu Y, Jiang Q, Zhang A, Stone GW.
    JACC Cardiovasc Interv; 2010 Jun 01; 3(6):632-41. PubMed ID: 20630456
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Is there a higher risk of stent thrombosis in bifurcation lesion or is it related to the technique?
    Iakovou I, Kadota K, Papamentzelopoulos S, Pavlides G, Mitsudo K.
    EuroIntervention; 2010 Dec 01; 6 Suppl J():J107-11. PubMed ID: 21930473
    [Abstract] [Full Text] [Related]

  • 35. Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions.
    Sheiban I, Infantino VA, Colombo F, Bollati M, Omedè P, Moretti C, Sciuto F, Siliquini R, Chiadò S, Trevi GP, Biondi-Zoccai G.
    Catheter Cardiovasc Interv; 2009 Aug 01; 74(2):313-20. PubMed ID: 19496110
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Interventional therapy of bifurcation lesions: a TIMI flow-guided concept to treat side branches in bifurcation lesions--a prospective randomized clinical study (Thueringer bifurcation study, THUEBIS study as pilot trial).
    Korn HV, Yu J, Ohlow MA, Huegl B, Schulte W, Wagner A, Wassmer G, Gruene S, Petek O, Lauer B.
    Circ Cardiovasc Interv; 2009 Dec 01; 2(6):535-42. PubMed ID: 20031771
    [Abstract] [Full Text] [Related]

  • 39. Long-term clinical outcomes following drug-eluting stent implantation for unprotected distal trifurcation left main disease: the Milan-New Tokyo (MITO) registry.
    Ielasi A, Takagi K, Latib A, Basavarajaiah S, Figini F, Carlino M, Montorfano M, Chieffo A, Nakamura S, Colombo A.
    Catheter Cardiovasc Interv; 2014 Mar 01; 83(4):530-8. PubMed ID: 23983065
    [Abstract] [Full Text] [Related]

  • 40. Long-term risk of clinical events from stenting side branches of coronary bifurcation lesions with drug-eluting and bare-metal stents: an observational meta-analysis.
    Zamani P, Kinlay S.
    Catheter Cardiovasc Interv; 2011 Feb 01; 77(2):202-12. PubMed ID: 20824754
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.